Process and device for measuring tear fluorescein clearance

• US 6,438,398 B1
• Filed: 03/03/2000
• Issued: 08/20/2002
• Est. Priority Date: 03/05/1999
• Status: Expired due to Fees

• Current Assignee: University of Miami
• Original Assignee: University of Miami
• Inventors: Pflugfelder, Stephen C., Tseng, Scheffer C. G., Macri, Angelo, Afonso, Adolfo
• Primary Examiner(s): Winakur, Eric F.
• Assistant Examiner(s): McCrosky, David
• Application Number:
  US09/518,693
• Time in Patent Office: 900 Days
• Field of Search: 600/321, 600/356, 385/901, 356/317
• US Class Current: 600/321
• CPC Class Codes: A61B 3/101 for examining the tear film
• CPC Class Codes: A61K 49/0043 Fluorescein, used in vivo
• CPC Class Codes: G01N 33/52 Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements immunological elements G01N33/54386; involving labelled immunochemicals G01N33/58; for haemoglobin or occult blood G01N33/72

Abstract

A method of evaluating clearance of fluorescein dye instilled into tear film having a greater sensitivity and specificity for diagnosing a tear film disorder as the cause of a patient'"'"'s ocular irritation and ocular surface disease than can be achieved using the traditional methods. The inventive method can be performed using a diagnostic kit for evaluating tear fluorescence clearance in which the concentration of tear fluorescein is visually quantified via a color standard.

Claims

1. A process of measuring tear clearance from a mammalian eye, comprising:

(a) instilling an effective amount of fluorescein dye solution into an inferior conjunctival sac of an eye;

(b) incubating the fluorescein dye solution in the conjunctival sac for a period of time sufficient to allow dye to mix with tear fluid;

(c) collecting a sample of the tear fluid from the eye;

(d) determining the volume of the tear fluid collected; and

(e) measuring an amount of fluorescence present in the tear fluid by comparison with a color standard.

2. The process according to claim 1, wherein the fluorescein dye solution comprises about 0.5% to about 2% fluorescein in saline.

3. The process according to claim 2, wherein the effective amount of the fluorescein dye solution comprises between about 0.5 microliters and about 5 microliters.

4. The process according to claim 1, wherein tear fluid is collected on a substrate for comparing the amount of fluorescence present in the tear fluid with a color standard.

5. The process according to claim 4, wherein the color standard comprises a color standard plate.

6. The process according to claim 4, wherein the substrate is a member selected from the group consisting of a filter paper strip and a polyester wick.

7. The method of claim 4, wherein measurement of the amount of fluorescence present in the tear fluid is performed by:

collecting volumes of tear fluid between 0.5 μ

l and 3 μ

l on a substrate, and

comparing the color of the fluorescein-stained substrate to a color standard.

8. The method of claim 7, wherein the color standard comprises a standard visual scale having scores ranging from 0 to 6, wherein a score of 3 corresponds to a fluorometric value of 274 fluorescein units/μ

l.

9. The process according to claim 1, wherein the amount of fluorescence present in tear fluid is measured directly from an inferior tear meniscus.

10. The process according to claim 9, wherein the amount of fluorescence present in tear fluid is directly measured from the inferior tear meniscus using a color standard viewed simultaneously with the inferior tear meniscus under a biomicroscope.

11. A process of detecting at least one ocular abnormality affecting tear flow, said process comprising:

(a) instilling an effective amount of fluorescein dye solution into an inferior conjunctival sac of an eye;

(b) incubating the fluorescein dye solution in the conjunctival sac for a period of time sufficient to allow the dye to mix with tear fluid;

(c) collecting a sample of tear fluid from the eye;

(d) determining the volume of tear fluid collected; and

(e) measuring the amount of fluorescence present in the tear fluid.

12. A process according to claim 11, wherein the ocular abnormality comprises a member selected from the group consisting of meibomian gland disease, conjunctivochalasis, lid laxity, tear outflow obstruction and blink abnormalities.

13. A process according to claim 11, wherein measurement of the amount of fluorescence present in the tear fluid is performed by:

collecting volumes of tear fluid between 0.5 μ

l to 3 μ

l on a substrate, and

comparing the color of the fluorescein-stained substrate to a color standard.

14. The process according to claim 13, wherein the substrate comprises a member selected from the group consisting of a filter paper strip and a polyester wick.

15. The process according to claim 13, wherein the color standard comprises a standardized visual scale having scores ranging from 0 to 6, wherein a score of 3 corresponds to a fluorophotometric value of 274 fluorescein units/μ

l.

16. The process according to claim 15, wherein sensitivity of measurements from the standardized visual scale are increased according to correction formula II:

$\begin{array}{cc}\mathrm{SVST}<br><br>\text{\hspace{1em}<br><br>}<br><br>\left(\mathrm{corrected}\right)=\mathrm{SVST}+\frac{\mathrm{Schirmer}<br><br>\text{\hspace{1em}<br><br>}<br><br>\mathrm{score}}{y}& \mathrm{II}\end{array}$

wherein coefficient y corresponds to an area under a Receiver Operating Characteristic (ROC) curve and the Schirmer score is obtained using Schirmer test strips placed over an eyelid margin.

17. A process of detecting at least one ocular abnormality affecting tear flow, said process comprising:

(a) instilling an effective amount of fluorescein dye solution into conjunctival sac of an eye;

(b) incubating the fluorescein dye solution in the conjunctival sac for a period of time sufficient to allow dye to mix with tear fluid;

(c) examining the eye surface with a biomicroscope to observe corneal fluorescein staining in each of four corneal quadrants;

(e) measuring fluorescence observed to obtain a corneal fluorescein staining score; and

(f) correlating the corneal fluorescein staining score with results from a Fluorescein Clearance Test (FCT) corrected according to correction formula I;

18. The process according to claim 17, wherein coefficient y is 4.

19. A diagnostic kit for measuring tear clearance comprising:

(a) an indicator suitable for introduction into an inferior conjunctival sac of an eye, the indicator comprising a member selected from the group consisting of a dye, an enzyme and a chemical; and

(b) a color standard for measuring indicator present in an inferior meniscus of an eye between about 5 and about 15 minutes after introduction of the indicator to the eye,

wherein the color standard comprises a standardized visual scale having scores corresponding to clinically relevant measures of tear clearance.

20. A diagnostic kit for measuring tear clearance comprising:

(a) a fluorescein dye solution suitable for introduction into an inferior conjunctival sac of an eye;

(b) a substrate for collecting a sample of tear fluid from the eye; and

(c) a color standard for measuring the amount of fluorescence preset in the tear fluid,

wherein the color standard comprises a standardized visual scale having scores corresponding to clinically relevant measures of tear clearance.

21. A diagnostic kit according to claim 20, wherein said fluorescein dye solution is introduced to the eye via a unit-dose dropperette.

22. A diagnostic kit according to claim 21, wherein said unit-dose dropperette administers dosages of about 0.5 microliters to about 5 microliters of fluorescein dye solution.

23. A diagnostic kit according to claim 20, wherein the color standard comprises a color photographic plate, optionally of a size appropriate for placement along a lower eyelid to be viewed under a biomicroscope simultaneously with an inferior tear meniscus.

24. A diagnostic kit according to claim 20, wherein the color standard comprises a standardized visual scale having scores ranging from 0 to 6, wherein a score of 3 corresponds to a fluorophotometric value of 274 fluorescein units/μ

l.

25. A diagnostic kit according to claim 24, wherein sensitivity of measurements from the standardized visual scale are improved according to correction formula II:

26. A process of measuring tear clearance from a mammalian eye, comprising:

(a) instilling an effective amount of an indicator solution into an inferior conjunctival sac of an eye, the indicator comprising a member selected from the group consisting of a dye, an enzyme and a chemical;

(b) incubating the indicator solution in the conjunctival sac for a period of time sufficient to allow indicator to mix with tear fluid; and

(c) collecting a sample of tear fluid from the eye;

(d) determining the volume of tear fluid collected; and

(e) measuring the amount of indicator in the tear fluid by comparison with a color standard, wherein the color standard comprises a standardized visualized scale having scores ranging from 0 to 6, wherein a score of 3 indicates the cut-off value between normality and abnormality.

27. The method of claim 26, wherein said indicator is fluorescein.

28. The method of claim 27, wherein said score of 3 corresponds to a fluorophotometric value of 274 fluorescein units/μ

l.

29. A process of measuring tear clearance from a mammalian eye, comprising:

(a) instilling an effective amount of an indicator solution into an inferior conjunctival sac of an eye, the indicator comprising a member selected from the group consisting of a dye, an enzyme and a chemical;

(b) incubating the indicator solution in the conjunctival sac for a period of time sufficient to allow indicator to mix with tear fluid; and

(c) measuring the amount of indicator in the tear fluid by comparison with a color standard, wherein the color standard comprises a standardized visualized scale having scores ranging from 0 to 6, wherein a score of 3 indicates the cut-off value between normality and abnormality.

30. The method of claim 29, wherein said indicator is fluorescein.

31. The method of claim 30, wherein said score of 3 corresponds to a fluorophotometric value of 274 fluorescein units/μ

l.

32. The method of claim 30, wherein the indicator is measured between about 5 and 15 minutes after introduction to the eye.